
### [MONDO:0018387](http://purl.obolibrary.org/obo/MONDO_0018387)
**Label:** rare male infertility due to adrenal disorder

**Subclasses:** [MONDO:0020527](http://purl.obolibrary.org/obo/MONDO_0020527) (ectopic Cushing syndrome), [MONDO:0017973](http://purl.obolibrary.org/obo/MONDO_0017973) (non-classic congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0020528](http://purl.obolibrary.org/obo/MONDO_0020528) (ACTH-dependent Cushing syndrome), [MONDO:0013664](http://purl.obolibrary.org/obo/MONDO_0013664) (46,XY disorder of sex development due to testicular 17,20-desmolase deficiency), [MONDO:0020529](http://purl.obolibrary.org/obo/MONDO_0020529) (ACTH-independent Cushing syndrome), [MONDO:0019597](http://purl.obolibrary.org/obo/MONDO_0019597) (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), [MONDO:0017840](http://purl.obolibrary.org/obo/MONDO_0017840) (classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form), [MONDO:0008730](http://purl.obolibrary.org/obo/MONDO_0008730) (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency), [MONDO:0009049](http://purl.obolibrary.org/obo/MONDO_0009049) (Cushing syndrome due to macronodular adrenal hyperplasia), [MONDO:0012509](http://purl.obolibrary.org/obo/MONDO_0012509) (pigmented nodular adrenocortical disease, primary, 1), [MONDO:0008728](http://purl.obolibrary.org/obo/MONDO_0008728) (classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency), [MONDO:0000084](http://purl.obolibrary.org/obo/MONDO_0000084) (pigmented nodular adrenocortical disease), [MONDO:0017839](http://purl.obolibrary.org/obo/MONDO_0017839) (classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form), [MONDO:0013616](http://purl.obolibrary.org/obo/MONDO_0013616) (pigmented nodular adrenocortical disease, primary, 3), [MONDO:0012505](http://purl.obolibrary.org/obo/MONDO_0012505) (pigmented nodular adrenocortical disease, primary, 2), [MONDO:0014359](http://purl.obolibrary.org/obo/MONDO_0014359) (pigmented nodular adrenocortical disease, primary, 4), [MONDO:0009050](http://purl.obolibrary.org/obo/MONDO_0009050) (ACTH-secreting pituitary adenoma), [MONDO:0014416](http://purl.obolibrary.org/obo/MONDO_0014416) (Acth-Independent macronodular adrenal hyperplasia 2), [MONDO:0015999](http://purl.obolibrary.org/obo/MONDO_0015999) (primary pigmented nodular adrenocortical disease), [MONDO:0018627](http://purl.obolibrary.org/obo/MONDO_0018627) (ACTH-independent Cushing syndrome due to rare cortisol-producing adrenal tumor), 

**Mapped go classes:** [GO:0043627](http://purl.obolibrary.org/obo/GO_0043627) (response to estrogen), [GO:0047787](http://purl.obolibrary.org/obo/GO_0047787) (delta4-3-oxosteroid 5beta-reductase activity), [GO:0045762](http://purl.obolibrary.org/obo/GO_0045762) (positive regulation of adenylate cyclase activity), [GO:0046580](http://purl.obolibrary.org/obo/GO_0046580) (negative regulation of Ras protein signal transduction), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0046069](http://purl.obolibrary.org/obo/GO_0046069) (cGMP catabolic process), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma), [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding), [GO:0000060](http://purl.obolibrary.org/obo/GO_0000060) (protein import into nucleus, translocation), [GO:0003729](http://purl.obolibrary.org/obo/GO_0003729) (mRNA binding), [GO:2000353](http://purl.obolibrary.org/obo/GO_2000353) (positive regulation of endothelial cell apoptotic process), [GO:0071379](http://purl.obolibrary.org/obo/GO_0071379) (cellular response to prostaglandin stimulus), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0016655](http://purl.obolibrary.org/obo/GO_0016655) (oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor), [GO:0004032](http://purl.obolibrary.org/obo/GO_0004032) (alditol:NADP+ 1-oxidoreductase activity), [GO:0047953](http://purl.obolibrary.org/obo/GO_0047953) (glycerol 2-dehydrogenase (NADP+) activity), [GO:0007265](http://purl.obolibrary.org/obo/GO_0007265) (Ras protein signal transduction), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0006694](http://purl.obolibrary.org/obo/GO_0006694) (steroid biosynthetic process), [GO:0004033](http://purl.obolibrary.org/obo/GO_0004033) (aldo-keto reductase (NADP) activity), [GO:0047555](http://purl.obolibrary.org/obo/GO_0047555) (3',5'-cyclic-GMP phosphodiesterase activity), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0004303](http://purl.obolibrary.org/obo/GO_0004303) (estradiol 17-beta-dehydrogenase activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0047442](http://purl.obolibrary.org/obo/GO_0047442) (17-alpha-hydroxyprogesterone aldolase activity), [GO:0047045](http://purl.obolibrary.org/obo/GO_0047045) (testosterone 17-beta-dehydrogenase (NADP+) activity), [GO:0016241](http://purl.obolibrary.org/obo/GO_0016241) (regulation of macroautophagy), [GO:0010942](http://purl.obolibrary.org/obo/GO_0010942) (positive regulation of cell death), [GO:0016488](http://purl.obolibrary.org/obo/GO_0016488) (farnesol catabolic process), [GO:0034614](http://purl.obolibrary.org/obo/GO_0034614) (cellular response to reactive oxygen species), [GO:0051897](http://purl.obolibrary.org/obo/GO_0051897) (positive regulation of protein kinase B signaling), [GO:0016229](http://purl.obolibrary.org/obo/GO_0016229) (steroid dehydrogenase activity), [GO:0007191](http://purl.obolibrary.org/obo/GO_0007191) (adenylate cyclase-activating dopamine receptor signaling pathway), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0090032](http://purl.obolibrary.org/obo/GO_0090032) (negative regulation of steroid hormone biosynthetic process), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0090031](http://purl.obolibrary.org/obo/GO_0090031) (positive regulation of steroid hormone biosynthetic process), [GO:0001403](http://purl.obolibrary.org/obo/GO_0001403) (invasive growth in response to glucose limitation), [GO:0008603](http://purl.obolibrary.org/obo/GO_0008603) (cAMP-dependent protein kinase regulator activity), [GO:0045703](http://purl.obolibrary.org/obo/GO_0045703) (ketoreductase activity), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0006700](http://purl.obolibrary.org/obo/GO_0006700) (C21-steroid hormone biosynthetic process), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0001772](http://purl.obolibrary.org/obo/GO_0001772) (immunological synapse), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:0071395](http://purl.obolibrary.org/obo/GO_0071395) (cellular response to jasmonic acid stimulus), [GO:0048385](http://purl.obolibrary.org/obo/GO_0048385) (regulation of retinoic acid receptor signaling pathway), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0004118](http://purl.obolibrary.org/obo/GO_0004118) (cGMP-stimulated cyclic-nucleotide phosphodiesterase activity), [GO:0071277](http://purl.obolibrary.org/obo/GO_0071277) (cellular response to calcium ion), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0048025](http://purl.obolibrary.org/obo/GO_0048025) (negative regulation of mRNA splicing, via spliceosome), [GO:0071276](http://purl.obolibrary.org/obo/GO_0071276) (cellular response to cadmium ion), [GO:0045550](http://purl.obolibrary.org/obo/GO_0045550) (geranylgeranyl reductase activity), [GO:0071799](http://purl.obolibrary.org/obo/GO_0071799) (cellular response to prostaglandin D stimulus), [GO:2000379](http://purl.obolibrary.org/obo/GO_2000379) (positive regulation of reactive oxygen species metabolic process), [GO:0031852](http://purl.obolibrary.org/obo/GO_0031852) (mu-type opioid receptor binding), [GO:0031698](http://purl.obolibrary.org/obo/GO_0031698) (beta-2 adrenergic receptor binding), [GO:0042448](http://purl.obolibrary.org/obo/GO_0042448) (progesterone metabolic process), [GO:0004090](http://purl.obolibrary.org/obo/GO_0004090) (carbonyl reductase (NADPH) activity), [GO:0016579](http://purl.obolibrary.org/obo/GO_0016579) (protein deubiquitination), [GO:0018636](http://purl.obolibrary.org/obo/GO_0018636) (phenanthrene 9,10-monooxygenase activity), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0035410](http://purl.obolibrary.org/obo/GO_0035410) (dihydrotestosterone 17-beta-dehydrogenase activity), [GO:1990042](http://purl.obolibrary.org/obo/GO_1990042) (glycerol dehydrogenase [NAD(P)+] activity), [GO:0004497](http://purl.obolibrary.org/obo/GO_0004497) (monooxygenase activity), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0042446](http://purl.obolibrary.org/obo/GO_0042446) (hormone biosynthetic process), [GO:0007005](http://purl.obolibrary.org/obo/GO_0007005) (mitochondrion organization), [GO:0042843](http://purl.obolibrary.org/obo/GO_0042843) (D-xylose catabolic process), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0001662](http://purl.obolibrary.org/obo/GO_0001662) (behavioral fear response), [GO:0071384](http://purl.obolibrary.org/obo/GO_0071384) (cellular response to corticosteroid stimulus), [GO:0006704](http://purl.obolibrary.org/obo/GO_0006704) (glucocorticoid biosynthetic process), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding), [GO:0001932](http://purl.obolibrary.org/obo/GO_0001932) (regulation of protein phosphorylation), [GO:0006705](http://purl.obolibrary.org/obo/GO_0006705) (mineralocorticoid biosynthetic process), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0006709](http://purl.obolibrary.org/obo/GO_0006709) (progesterone catabolic process), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0036459](http://purl.obolibrary.org/obo/GO_0036459) (thiol-dependent ubiquitinyl hydrolase activity), [GO:1900053](http://purl.obolibrary.org/obo/GO_1900053) (negative regulation of retinoic acid biosynthetic process), [GO:0044597](http://purl.obolibrary.org/obo/GO_0044597) (daunorubicin metabolic process), [GO:0042574](http://purl.obolibrary.org/obo/GO_0042574) (retinal metabolic process), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0008542](http://purl.obolibrary.org/obo/GO_0008542) (visual learning), [GO:0044598](http://purl.obolibrary.org/obo/GO_0044598) (doxorubicin metabolic process), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:1903449](http://purl.obolibrary.org/obo/GO_1903449) (androst-4-ene-3,17-dione biosynthetic process), [GO:0005952](http://purl.obolibrary.org/obo/GO_0005952) (cAMP-dependent protein kinase complex), [GO:0005159](http://purl.obolibrary.org/obo/GO_0005159) (insulin-like growth factor receptor binding), [GO:0004862](http://purl.obolibrary.org/obo/GO_0004862) (cAMP-dependent protein kinase inhibitor activity), [GO:0007606](http://purl.obolibrary.org/obo/GO_0007606) (sensory perception of chemical stimulus), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0010737](http://purl.obolibrary.org/obo/GO_0010737) (protein kinase A signaling), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0019568](http://purl.obolibrary.org/obo/GO_0019568) (arabinose catabolic process), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0031313](http://purl.obolibrary.org/obo/GO_0031313) (extrinsic component of endosome membrane), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0045859](http://purl.obolibrary.org/obo/GO_0045859) (regulation of protein kinase activity), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0008395](http://purl.obolibrary.org/obo/GO_0008395) (steroid hydroxylase activity), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0004112](http://purl.obolibrary.org/obo/GO_0004112) (cyclic-nucleotide phosphodiesterase activity), [GO:0004115](http://purl.obolibrary.org/obo/GO_0004115) (3',5'-cyclic-AMP phosphodiesterase activity), [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity), [GO:0071560](http://purl.obolibrary.org/obo/GO_0071560) (cellular response to transforming growth factor beta stimulus), [GO:0047086](http://purl.obolibrary.org/obo/GO_0047086) (ketosteroid monooxygenase activity), [GO:0004745](http://purl.obolibrary.org/obo/GO_0004745) (retinol dehydrogenase activity), [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0004508](http://purl.obolibrary.org/obo/GO_0004508) (steroid 17-alpha-monooxygenase activity), [GO:0001758](http://purl.obolibrary.org/obo/GO_0001758) (retinal dehydrogenase activity), [GO:0006805](http://purl.obolibrary.org/obo/GO_0006805) (xenobiotic metabolic process), [GO:0004509](http://purl.obolibrary.org/obo/GO_0004509) (steroid 21-monooxygenase activity), [GO:0061370](http://purl.obolibrary.org/obo/GO_0061370) (testosterone biosynthetic process), [GO:0050885](http://purl.obolibrary.org/obo/GO_0050885) (neuromuscular process controlling balance), [GO:0035106](http://purl.obolibrary.org/obo/GO_0035106) (operant conditioning), [GO:0016705](http://purl.obolibrary.org/obo/GO_0016705) (oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0047006](http://purl.obolibrary.org/obo/GO_0047006) (17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity), [GO:0005496](http://purl.obolibrary.org/obo/GO_0005496) (steroid binding), [GO:0046676](http://purl.obolibrary.org/obo/GO_0046676) (negative regulation of insulin secretion), [GO:0043204](http://purl.obolibrary.org/obo/GO_0043204) (perikaryon), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0097271](http://purl.obolibrary.org/obo/GO_0097271) (protein localization to bud neck), [GO:0005930](http://purl.obolibrary.org/obo/GO_0005930) (axoneme), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0007548](http://purl.obolibrary.org/obo/GO_0007548) (sex differentiation), [GO:0071470](http://purl.obolibrary.org/obo/GO_0071470) (cellular response to osmotic stress), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0019388](http://purl.obolibrary.org/obo/GO_0019388) (galactose catabolic process), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0050810](http://purl.obolibrary.org/obo/GO_0050810) (regulation of steroid biosynthetic process), [GO:0008081](http://purl.obolibrary.org/obo/GO_0008081) (phosphoric diester hydrolase activity), [GO:0032866](http://purl.obolibrary.org/obo/GO_0032866) (D-xylose:NADP reductase activity), [GO:0006071](http://purl.obolibrary.org/obo/GO_0006071) (glycerol metabolic process), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0004691](http://purl.obolibrary.org/obo/GO_0004691) (cAMP-dependent protein kinase activity), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0006198](http://purl.obolibrary.org/obo/GO_0006198) (cAMP catabolic process), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0007567](http://purl.obolibrary.org/obo/GO_0007567) (parturition), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0047020](http://purl.obolibrary.org/obo/GO_0047020) (15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity), [GO:0003755](http://purl.obolibrary.org/obo/GO_0003755) (peptidyl-prolyl cis-trans isomerase activity), [GO:0042493](http://purl.obolibrary.org/obo/GO_0042493) (response to drug), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0047023](http://purl.obolibrary.org/obo/GO_0047023) (androsterone dehydrogenase activity), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0034599](http://purl.obolibrary.org/obo/GO_0034599) (cellular response to oxidative stress), [GO:0030552](http://purl.obolibrary.org/obo/GO_0030552) (cAMP binding), [GO:0071901](http://purl.obolibrary.org/obo/GO_0071901) (negative regulation of protein serine/threonine kinase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0030553](http://purl.obolibrary.org/obo/GO_0030553) (cGMP binding), [GO:2000224](http://purl.obolibrary.org/obo/GO_2000224) (regulation of testosterone biosynthetic process), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- Thing 55.54%
- [GO:1990042](http://purl.obolibrary.org/obo/GO_1990042) (glycerol dehydrogenase [NAD(P)+] activity) 50.67%
- [GO:0047953](http://purl.obolibrary.org/obo/GO_0047953) (glycerol 2-dehydrogenase (NADP+) activity) 50.67%
- [GO:0047086](http://purl.obolibrary.org/obo/GO_0047086) (ketosteroid monooxygenase activity) 50.67%
- [GO:0047045](http://purl.obolibrary.org/obo/GO_0047045) (testosterone 17-beta-dehydrogenase (NADP+) activity) 50.67%
- [GO:0047020](http://purl.obolibrary.org/obo/GO_0047020) (15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity) 50.67%
- [GO:0047006](http://purl.obolibrary.org/obo/GO_0047006) (17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity) 50.67%
- [GO:0045703](http://purl.obolibrary.org/obo/GO_0045703) (ketoreductase activity) 50.67%
- [GO:0045550](http://purl.obolibrary.org/obo/GO_0045550) (geranylgeranyl reductase activity) 50.67%
- [GO:0035410](http://purl.obolibrary.org/obo/GO_0035410) (dihydrotestosterone 17-beta-dehydrogenase activity) 50.67%
- [GO:0032866](http://purl.obolibrary.org/obo/GO_0032866) (D-xylose:NADP reductase activity) 50.67%
- [GO:0018636](http://purl.obolibrary.org/obo/GO_0018636) (phenanthrene 9,10-monooxygenase activity) 50.67%
- [GO:0008603](http://purl.obolibrary.org/obo/GO_0008603) (cAMP-dependent protein kinase regulator activity) 50.67%
- [GO:0004862](http://purl.obolibrary.org/obo/GO_0004862) (cAMP-dependent protein kinase inhibitor activity) 50.67%
- [GO:0004745](http://purl.obolibrary.org/obo/GO_0004745) (retinol dehydrogenase activity) 50.67%


